Andrew Callos
Evp, Chief Commercial Officer at Cytokinetics Inc (CYTK)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 31SEC | CYTKCytokinetics Inc | Sell Plan | 10,00058,555 held (−15%) | $70.24 | $702K | -10.4% |
| Jul 30SEC | CYTKCytokinetics Inc | Sell Plan | 14,00058,555 held (−19%) | $79.88 | $1.1M | -21.2% |
| Jul 2SEC | CYTKCytokinetics Inc | Sell Plan | 15,00058,555 held (−20%) | $85.80 | $1.3M | -26.7% |
| Jun 1SEC | CYTKCytokinetics Inc | Sell Plan | 15,00058,555 held (−20%) | $74.08 | $1.1M | -15.1% |
| May 5SEC | CYTKCytokinetics Inc | Sell Plan | 11,33358,555 held (−16%) | $77.25 | $875K | -18.6% |
| May 4SEC | CYTKCytokinetics Inc | Sell Plan | 15,85758,555 held (−21%) | $65.00 | $1.0M | -3.2% |
| Apr 30SEC | CYTKCytokinetics Inc | Sell Plan | 15,00058,555 held (−20%) | $63.26 | $949K | -0.6% |
| Apr 15SEC | CYTKCytokinetics Inc | Sell Plan | 7,44958,555 held (−11%) | $66.02 | $492K | -4.7% |
| Mar 31SEC | CYTKCytokinetics Inc | Sell Plan | 3,63966,004 held (−5%) | $65.00 | $237K | -3.2% |
| Mar 18SEC | CYTKCytokinetics Inc | Sell Plan | 1,93078,185 held (−2%) | $62.07 | $120K | +1.4% |
| Mar 18SEC | CYTKCytokinetics Inc | Sell | 5,62674,489 held (−7%) | $62.15 | $350K | +1.2% |
| Mar 18SEC | CYTKCytokinetics Inc | Sell | 2,91671,573 held (−4%) | $62.15 | $181K | +1.2% |
| Mar 16SEC | CYTKCytokinetics Inc | Sell Plan | 1,70946,149 held (−4%) | $61.03 | $104K | +3.1% |
| Mar 10SEC | CYTKCytokinetics Inc | Sell | 2,58247,858 held (−5%) | $60.72 | $157K | +3.6% |
| Mar 5SEC | CYTKCytokinetics Inc | Sell Plan | 15,00061,440 held (−20%) | $61.87 | $928K | +1.7% |
| Mar 5SEC | CYTKCytokinetics Inc | Sell Plan | 11,00050,440 held (−18%) | $61.88 | $681K | +1.7% |
| Mar 2SEC | CYTKCytokinetics Inc | Sell Plan | 88650,440 held (−2%) | $61.62 | $55K | +2.1% |
| Feb 5SEC | CYTKCytokinetics Inc | Sell Plan | 15,00050,440 held (−23%) | $61.93 | $929K | +1.6% |
| Feb 2SEC | CYTKCytokinetics Inc | Sell Plan | 88650,440 held (−2%) | $62.10 | $55K | +1.3% |
| Jan 5SEC | CYTKCytokinetics Inc | Sell Plan | 15,00050,440 held (−23%) | $60.28 | $904K | +4.4% |
| Jan 2SEC | CYTKCytokinetics Inc | Sell Plan | 91350,440 held (−2%) | $62.09 | $57K | +1.3% |
| Jan 2SEC | CYTKCytokinetics Inc | Sell Plan | 88550,440 held (−2%) | $63.16 | $56K | -0.4% |
| Dec 30SEC | CYTKCytokinetics Inc | Sell Plan | 1,80951,353 held (−3%) | $62.44 | $113K | +0.8% |
| Dec 8SEC | CYTKCytokinetics Inc | Sell Plan | 1,04250,660 held (−2%) | $65.96 | $69K | -4.6% |
| Dec 5SEC | CYTKCytokinetics Inc | Sell Plan | 52,48650,660 held (−51%) | $65.95 | $3.5M | -4.6% |
- Sell
Evp, Chief Commercial Officer Andrew Callos sold $702K of CYTK at $70.24 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Andrew Callos sold $1.1M of CYTK at $79.88 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Andrew Callos sold $1.3M of CYTK at $85.80 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Andrew Callos sold $1.1M of CYTK at $74.08 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Andrew Callos sold $875K of CYTK at $77.25 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Andrew Callos sold $1.0M of CYTK at $65.00 — pre-scheduled 10b5-1 plan sale.